By detecting the expression of surface biomarkers on tumor cells and immune cells before and after co-culture, antibodies targeting MICA/B and NKG2A were also found to enhance the killing effect of T cells and NK cells on colorectal cancer organoids, thus providing a potential target for the treatment of CRC [33]. This evidence concerns the gene KLRC1 and neoplasm.